FDA Adverse Event Other Summary report: N

SURGICAL FIBER

MDR report key: 851304 · Received May 7, 2007

Report

Report Number
2914019-2003-00020
Event Type
Other
Date Received
May 7, 2007
Date of Event
October 15, 2003
Report Date
May 7, 2007
Manufacturer
LUMENIS LTD
Product Code
GEX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US

Narratives

Additional Manufacturer Narrative · 1

THE LASER USED DURING THE PROCEDURE WAS A COHERENT HOLMIUM SURGICAL LASER IDENTIFIED BY THE ENDUSER. THE FIBER USED DURING THE PROCEDURE WAS A SLIMLINE 200 (IDENTIFIED BY THE ENDUSER, WHICH NUMBER DOES NOT CORRESPOND TO A LUMENIS LOT NUMBER). THE SLIMLINE 200 IS A REUSABLE SURGICAL FIBER. AS OF 2007, IT IS NOT KNOWN TO LUMENIS WHETHER THE SUBJECT SLIMLINE 200 FIBER WAS USED PRIOR TO THE PROCEDURE IN QUESTION. PER THE LASER LOG RECORDED BY THE MOBILE LASER PROVIDER, THERE WERE NO EQUIPMENT PROBLEMS DURING THE PROCEDURE. PT ALLEGES THAT THE LASER FIBER FRACTURED AND BURNED A HOLE IN THE SIDE OF THE URETEROSCOPE AND THROUGH THE PT'S URETER. PER THE PHYSICIAN, THE URETER WAS TORN DURING INSERTION OF THE SCOPE, A STANDARD RISK ASSOCIATED WITH THIS PROCEDURE. NO FURTHER CONCLUSION CAN BE DRAWN AT THIS TIME REGARDING ROOT CAUSE OF THE INCIDENT.

Description of Event or Problem · 1

PT ALLEGES THAT DURING A LITHOTRIPSY PROCEDURE, THE SLIMLINE 200 LASER FIBER FRACTURED AND BURNED A HOLE IN THE SIDE OF THE URETEROSCOPE AND THROUGH THE PT'S URETER. PER THE PHYSICIAN, THE URETER WAS TORN DURING INSERTION OF THE SCOPE, A STANDARD RISK ASSOCIATED WITH THIS PROCEDURE. PER THE PHYSICIAN, THE FIBERS DID FRACTURE, AND THE PHYSICIAN HAD TO CLEAN THE FRAGMENTS OUT OF THE PT'S BLADDER AND SURROUNDING TISSUE, WHICH CAUSED THE SURGERY TO LAST LONGER THAN THE PHYSICIAN WOULD HAVE LIKED, AND MAY HAVE CAUSED A LARGER ACCUMULATION OF FLUID THAT HAD TO BE REMOVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SURGICAL FIBER HO:YAG/ND:YAG SURGICAL LASER FIBER DELIVERY DEVICE GEX LUMENIS LTD SLIMLINE 200 UNK

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention NONE REPORTED